Journal of Labelled Compounds and Radiopharmaceuticals · 2016 · 37 citations · 13 references
Natural SciencesBiochemistryChemistryAnalytical ChemistryAnalytical ToxicologyMass Spectrometric AnalysisDrug-metabolizing EnzymesMass SpectrometryMetabolite QuantificationAssayAssay SensitivityHigh-sensitivity AssaysLiquid Chromatography-mass SpectrometryMass Spectrometric QuantificationOxidoreductase ActivityOxidoreductase EnzymesQuadrupole Mass Spectrometry
In this study, we developed a highly sensitive assay for xanthine oxidoreductase (XOR) activity utilizing a combination of [(13) C2 ,(15) N2 ]xanthine and liquid chromatography (LC)/triple quadrupole mass spectrometry (TQMS). In this assay, the amount of [(13) C2 ,(15) N2 ]uric acid (UA) produced by XOR was determined by using LC/TQMS. For this assay, we synthesized [(13) C2 ,(15) N2 ]xanthine as a substrate, [(13) C2 ,(15) N2 ]UA as an analytical standard, and [(13) C3 ,(15) N3 ]UA as an internal standard. The [(13) C2 ,(15) N2 ]UA calibration curve obtained using LC/TQMS under the selected reaction monitoring mode was evaluated, and the results indicated good linearity (R(2) = 0.998, weighting of 1/x(2) ) in the range of 20 to 4000 nM. As a model reaction of less active samples, the XOR activity of serial-diluted mouse plasma was measured. Thereby, the XOR activity of the 1024-fold-diluted mouse plasma was 4.49 ± 0.44 pmol/100 μL/h (mean ± standard deviation, n = 3). This value is comparable to the predicted XOR activity value of healthy human plasma. Hence, this combination method may be used to obtain high-sensitivity measurements required for XOR activity analysis on various organs or human plasma.
13
Uric Acid Secretion from Adipose Tissue and Its Increase in Obesity
Yu Tsushima, Hitoshi Nishizawa, Yoshihiro Tochino et al. · Journal of Biological Chemistry · 2013 · 389 citations · Full text